{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T05:12:03Z","timestamp":1792127523911,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.clinthera.2009.01.016","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T14:52:38Z","timestamp":1235487158000},"page":"99-107","source":"Crossref","is-referenced-by-count":41,"title":["Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergie rhinitis: A phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults"],"prefix":"10.1016","volume":"31","author":[{"given":"Shailen R.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjuli","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Roland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Michael Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.01.016_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/jop.1996.12.389","article-title":"The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic\/ antihistamine agent","volume":"12","author":"Yanni","year":"1996","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2009.01.016_bib2","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/S0149-2918(03)80315-6","article-title":"Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans","volume":"25","author":"Leonardi","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2009.01.016_bib3","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0022-3565(25)20776-5","article-title":"Characterization of the ocular antiallergic and antihistamine effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases","volume":"278","author":"Sharif","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clinthera.2009.01.016_bib4","first-page":"809","article-title":"Properties of olopatadine hydrochloride, a new antiallergic\/ antihistamine drug","volume":"54","author":"Ohmori","year":"2004","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.clinthera.2009.01.016_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1254\/jjp.88.379","article-title":"Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug","volume":"88","author":"Ohmori","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.clinthera.2009.01.016_bib6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)61174-X","article-title":"Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar","volume":"95","author":"Ratner","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2009.01.016_bib7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1081-1206(10)61025-3","article-title":"Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis","volume":"95","author":"Meltzer","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"Suppl 5","key":"10.1016\/j.clinthera.2009.01.016_bib8","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1067\/mai.2001.118891","article-title":"Allergic rhinitis and its impact on asthma","volume":"108","author":"Bousquet","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.01.016_bib9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: An updated practice parameter","volume":"122","author":"Wallace","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.01.016_bib10","first-page":"185","article-title":"Demographics and epidemiology of allergic and nonallelic rhinitis","volume":"22","author":"Settipane","year":"2001","journal-title":"Allergy Asthma Proc"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2009.01.016_bib11","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1067\/mai.2001.115569","article-title":"Allergic rhinitis: Definition, epidemiology, pathophysiology, detection, and diagnosis","volume":"108","author":"Skoner","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.01.016_bib12","first-page":"265","article-title":"Allergic rhinoconjunctivitis: Diagnostic and clinical assessment","volume":"30","author":"Salzano","year":"1992","journal-title":"Rhmology"},{"key":"10.1016\/j.clinthera.2009.01.016_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/23771003.1996.12314896","article-title":"Allergicrhinocon-junctivitis: Current therapy","volume":"31","author":"Hollingsworth","year":"1996","journal-title":"Hosp Pract (Minneap)"},{"key":"10.1016\/j.clinthera.2009.01.016_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mcna.2005.08.011","article-title":"Allergic rhinitis: Impact of the disease and considerations for management","volume":"90","author":"Greiner","year":"2006","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.clinthera.2009.01.016_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.amjmed.2005.06.015","article-title":"Allergic rhinitis: Treatment based on patient profiles","volume":"119","author":"Prenner","year":"2006","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2009.01.016_bib16","doi-asserted-by":"crossref","first-page":"S390","DOI":"10.1016\/j.jaci.2004.12.014","article-title":"Clinical outcomes and adverse effect monitoring in allergic rhinitis","volume":"115","author":"Juniper","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.01.016_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00063030-200115070-00004","article-title":"Clinical prescribing of allergic rhinitis medication in the preschool and young school-age child: What are the options?","volume":"15","author":"Galant","year":"2001","journal-title":"BioDrugs"},{"key":"10.1016\/j.clinthera.2009.01.016_bib18","series-title":"Astehn (azelastine hydrochloride) [package insert]","year":"2007"},{"key":"10.1016\/j.clinthera.2009.01.016_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2222.1991.tb00807.x","article-title":"Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis","volume":"21","author":"Juniper","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinthera.2009.01.016_bib20","series-title":"Quality of Life and Pharmacoeconomics in Clinical Trials","first-page":"49","article-title":"How to develop and validate a new health related quality of life instrument","author":"Juniper","year":"1996"},{"key":"10.1016\/j.clinthera.2009.01.016_bib21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1185\/030079905X41408","article-title":"Open-label evaluation ofazelastine nasal spray in patients with seasonal allergic rhinitis and nonallelic vasomotor rhinitis","volume":"21","author":"Lieberman","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2009.01.016_bib22","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/0091-6749(94)90115-5","article-title":"A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model","volume":"94","author":"Weiler","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.01.016_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1517\/14656566.8.5.701","article-title":"Review of azelastine nasal spray in the treatment of allergic and non-allergic rhinitis","volume":"8","author":"Lee","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.clinthera.2009.01.016_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1081-1206(10)62179-5","article-title":"Efficacy of azelastine nasal spray in patients with an unsatisfactory response to lorata-dine","volume":"91","author":"Berger","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2009.01.016_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1081-1206(10)61468-8","article-title":"Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine","volume":"93","author":"LaForce","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2009.01.016_bib26","first-page":"45","article-title":"The Medical Letter on Drugs and Therapeutics","volume":"39","year":"1997"},{"key":"10.1016\/j.clinthera.2009.01.016_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.otohns.2004.04.011","article-title":"Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis","volume":"131","author":"Stokes","year":"2004","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809000307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809000307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T21:38:32Z","timestamp":1738964312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809000307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0149291809000307"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.01.016","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}